Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
NCT ID:
NCT03817320
Population Description:
Zero patients enrolled on Dose Level -1 of Stratum A as the Dose Level 1 and 2 were deemed safe in Phase I of the study. Dose Level 2 was used as the dose expansion for Phase II. Response-evaluable Stratum A patients treated at the PO RP2D in phase 1 will be included in the phase 2 analysis as per Section 10.1.2 of the study protocol.
Study:
NCT03817320
Study Brief:
Results Section:
NCT03817320